Regulation of Functional Amyloid Formation and Pigmentation During Melanosome Biogenesis

Regulation of Functional Amyloid Formation and Pigmentation During Melanosome Biogenesis

University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2015 Regulation of Functional Amyloid formation and Pigmentation During Melanosome Biogenesis Tina Ho University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Molecular Biology Commons Recommended Citation Ho, Tina, "Regulation of Functional Amyloid formation and Pigmentation During Melanosome Biogenesis" (2015). Publicly Accessible Penn Dissertations. 1768. https://repository.upenn.edu/edissertations/1768 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1768 For more information, please contact [email protected]. Regulation of Functional Amyloid formation and Pigmentation During Melanosome Biogenesis Abstract Melanosomes are subcellular organelles specialized for the synthesis and storage of melanin pigments. Within epidermal and ocular pigment cells, melanosomes are generated from endosomal precursors in discrete stages. Early stages are characterized by the accumulation of premelanosome protein (PMEL) and its assembly into nontoxic amyloid fibrils, while later stages are characterized by the arrival of proteins important for the production of pigment. In this thesis, I will discuss two important findings relevant to melanosome biology. The first finding addresses the molecular mechanisms that regulate the transformation of PMEL from an integral membrane protein to fibrillar structures with properties of amyloid. These data show that native disulfide-bonded PMEL dimers prevent premature fibril formation early in the secretory pathway but must be resolved prior to the assembly of functional amyloid fibrils in early stage melanosomes. ailurF e to resolve the dimeric intermediates – as occurs with mutagenesis of a PMEL regulatory domain – decreases amyloid production in a heterologous expression system. Since the oligomerization of amyloid precursors is hardly unique, detailed characterization of the different intermediates formed by functional versus pathological amyloid proteins may bring us one step closer to understanding the mechanisms of neurodegenerative amyloid disease. The second finding addresses the localization and potential function of SLC45A2, a proton-dependent sucrose transporter encoded by the gene that is mutated in the hypopigmentary disorder oculocutaneous albinism type 4 (OCA4). While melanocytes derived from patients and mouse models of OCA4 are known to contain hypopigmented melanosomes, it is unclear why mutations in SLC45A2 lead to decreased pigment production. Our data show that SLC45A2 localizes to and functions from distinct punctate structures on/near stage III and IV melanosomes. Mislocalization of SLC45A2 leads to hypopigmentation suggesting that the transporter must be present on melanosomal structures to function. Preliminary data also suggest that SLC45A2-deficient melanocytes harbor melanosomes that are hypopigmented but normally shaped and that SLC45A2 function can be bypassed by overexpression of a different melanosomal transporter, OCA2. Along with other preliminary data, these results suggest that SLC45A2 likely maintains a neutral pH within maturing melanosomes to ensure sustained melanin deposition. Together, these two studies provide insight into the molecular mechanisms that regulate nontoxic amyloid and melanin production within healthy melanocytes. Degree Type Dissertation Degree Name Doctor of Philosophy (PhD) Graduate Group Cell & Molecular Biology First Advisor Michael S. Marks Keywords disulfide, fibril, melanosome, membrane trafficking, Pmel17, protein aggregation Subject Categories Molecular Biology This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/1768 REGULATION OF FUNCTIONAL AMYLOID FORMATION AND PIGMENTATION DURING MELANOSOME BIOGENESIS Tina Ho A DISSERTATION in Cell and Molecular Biology Presented to the Faculties of the University of Pennsylvania in Partial Fulfillment of the requirements for the Degree of Doctor of Philosophy 2015 Supervisor of Dissertation _____________________ Michael S. Marks Professor of Pathology and Laboratory Medicine Graduate Group Chairperson _____________________ Daniel S. Kessler, Associate Professor of Cell and Developmental Biology Dissertation Committee Robert W. Doms, Professor of Pathology and Laboratory Medicine Rahul M. Kohli, Assistant Professor of Medicine and Biochemistry and Biophysics Virginia M.Y. Lee, Professor of Pathology and Laboratory Medicine James Shorter, Associate Professor of Biochemistry and Biophysics ABSTRACT REGULATION OF FUNCTIONAL AMYLOID FORMATION AND PIGMENTATION DURING MELANOSOME BIOGENESIS Tina Ho Michael S. Marks Melanosomes are subcellular organelles specialized for the synthesis and storage of melanin pigments. Within epidermal and ocular pigment cells, melanosomes are generated from endosomal precursors in discrete stages. Early stages are characterized by the accumulation of premelanosome protein (PMEL) and its assembly into nontoxic amyloid fibrils, while later stages are characterized by the arrival of proteins important for the production of pigment. In this thesis, I will discuss two important findings relevant to melanosome biology. The first finding addresses the molecular mechanisms that regulate the transformation of PMEL from an integral membrane protein to fibrillar structures with properties of amyloid. These data show that native disulfide-bonded PMEL dimers prevent premature fibril formation early in the secretory pathway but must be resolved prior to the assembly of functional amyloid fibrils in early stage melanosomes. Failure to resolve the dimeric intermediates – as occurs with mutagenesis of a PMEL regulatory domain – decreases amyloid production in a heterologous expression system. Since the oligomerization of ii amyloid precursors is hardly unique, detailed characterization of the different intermediates formed by functional versus pathological amyloid proteins may bring us one step closer to understanding the mechanisms of neurodegenerative amyloid disease. The second finding addresses the localization and potential function of SLC45A2, a proton-dependent sucrose transporter encoded by the gene that is mutated in the hypopigmentary disorder oculocutaneous albinism type 4 (OCA4). While melanocytes derived from patients and mouse models of OCA4 are known to contain hypopigmented melanosomes, it is unclear why mutations in SLC45A2 lead to decreased pigment production. Our data show that SLC45A2 localizes to and functions from distinct punctate structures on/near stage III and IV melanosomes. Mislocalization of SLC45A2 leads to hypopigmentation suggesting that the transporter must be present on melanosomal structures to function. Preliminary data also suggest that SLC45A2- deficient melanocytes harbor melanosomes that are hypopigmented but normally shaped and that SLC45A2 function can be bypassed by overexpression of a different melanosomal transporter, OCA2. Along with other preliminary data, these results suggest that SLC45A2 likely maintains a neutral pH within maturing melanosomes to ensure sustained melanin deposition. Together, these two studies provide insight into the molecular mechanisms that regulate nontoxic amyloid and melanin production within healthy melanocytes. iii TABLE OF CONTENTS ABSTRACT ........................................................................................................................ ii LIST OF TABLES ............................................................................................................. vi LIST OF FIGURES .......................................................................................................... vii CHAPTER 1 Introduction: Functional Amyloid and Melanosome Biogenesis ...........1 1.1 Introduction ........................................................................................................2 1.2 Amyloid .............................................................................................................4 1.2.1 Aβ and Alzheimer Disease .................................................................7 1.2.2 α-Synuclein and Parkinson Disease ....................................................8 1.2.3 Functional amyloid .............................................................................9 1.2.4 PMEL amyloid ..................................................................................13 1.2.5 PMEL regulation ...............................................................................16 1.3 Stage III and stage IV melanosomes ................................................................23 1.3.1 Melanosomal proteins associated with oculocutanous albinism ......23 1.3.2 Trafficking of melanosomal cargo ....................................................25 1.3.3 SLC45A2 ..........................................................................................26 1.4 Dissertation Aims .............................................................................................27 CHAPTER 2 Dimerization prevents PMEL functional amyloid formation in early secretory compartments ..................................................................................................29 Abstract ..................................................................................................................30 Introduction ............................................................................................................31 Results

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    160 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us